TXG
10x Genomics Inc
$13.29
Earnings Summary
Revenue | $151.65Mn |
Net Profits | $-35.75Mn |
Net Profit Margins | -23.58% |
Highlights
10x Genomics Inc’s revenue fell -1.3% since last year same period to $151.65Mn in the Q3 2024. On a quarterly growth basis, 10x Genomics Inc has generated -0.95% fall in its revenue since last 3-months.
10x Genomics Inc’s net profit jumped 61.55% since last year same period to $-35.75Mn in the Q3 2024. On a quarterly growth basis, 10x Genomics Inc has generated 5.66% jump in its net profits since last 3-months.
10x Genomics Inc’s net profit margin jumped 61.05% since last year same period to -23.58% in the Q3 2024. On a quarterly growth basis, 10x Genomics Inc has generated 4.76% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the 10x Genomics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.34 |
EPS Estimate Current Year | -0.34 |
Highlights
10x Genomics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.34 - a 29.17% jump from last quarter’s estimates.
10x Genomics Inc’s earning per share (EPS) estimates for the current year stand at -0.34.
Key Ratios
Key ratios of the 10x Genomics Inc post its Q3 2024 earnings
Earning Per Share (EPS) | -0.3 |
Highlights
10x Genomics Inc’s earning per share (EPS) jumped 62.03% since last year same period to -0.3 in the Q3 2024. This indicates that the 10x Genomics Inc has generated 62.03% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-04-30 | -0.5 | -0.5 | 0% |
2024-10-29 | -0.34 | -0.3 | 11.76% |
2024-08-08 | -0.48 | -0.32 | 33.33% |
₹0 US Stocks a/c Opening Fee